Liquidia

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Liquidia 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LQDA

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC. 

CEO
Roger A. Jeffs
CEORoger A. Jeffs
Employees
216
Employees216
Headquarters
Morrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded
2004
Founded2004
Employees
216
Employees216

LQDA Key Statistics

Market cap
3.82B
Market cap3.82B
Price-Earnings ratio
29.09
Price-Earnings ratio29.09
Dividend yield
—
Dividend yield—
Average volume
6.30M
Average volume6.30M
High today
$42.82
High today$42.82
Low today
$38.69
Low today$38.69
Open price
$39.86
Open price$39.86
Volume
3.80M
Volume3.80M
52 Week high
$93.61
52 Week high$93.61
52 Week low
$21.94
52 Week low$21.94

Stock Snapshot

As of today, Liquidia(LQDA) shares are valued at $42.59. The company's market cap stands at 3.82B, with a P/E ratio of 29.09.

As of 2026-10-23, Liquidia(LQDA) stock has fluctuated between $38.69 and $42.82. The current price stands at $42.59, placing the stock +10.1% above today's low and -0.5% off the high.

The Liquidia(LQDA)'s current trading volume is 3.8M, compared to an average daily volume of 6.3M.

During the past year, Liquidia(LQDA) stock moved between $21.94 at its lowest and $93.61 at its peak.

During the past year, Liquidia(LQDA) stock moved between $21.94 at its lowest and $93.61 at its peak.

LQDA News

TipRanks 1d
United Therapeutics price target lowered to $697 from $708 at RBC Capital

RBC Capital lowered the firm’s price target on United Therapeutics (UTHR) to $697 from $708 and keeps an Outperform rating on the shares. The top questions from...

Simply Wall St 3d
Learn Why The Bull Case For Liquidia Stock Could Change Following Patent Dispute Settlement

Liquidia settled its long running patent, trade secret and antitrust dispute with United Therapeutics by agreeing to pay US$380.7 million and removing the PH IL...

Learn Why The Bull Case For Liquidia Stock Could Change Following Patent Dispute Settlement

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own LQDA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.